Autistic Spectrum Disorder and the fragile X premutation

Journal of Developmental and Behavioral Pediatrics

Volumn 25, Issue 6, 2004, Pages 392-398

  Goodlin Jones, Beth L ^a   Tassone, Flora ^b   Gane, Louise W ^a   Hagerman, Randi J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Fragile X syndrome; Premutation

Indexed keywords

CARBAMAZEPINE; COMPLEMENTARY DNA; FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; VALPROIC ACID;

ADULT; ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DNA DETERMINATION; ENVIRONMENTAL FACTOR; FEMALE; FRAGILE X SYNDROME; GENE MUTATION; HOSPITALIZATION; HUMAN; INDIVIDUALITY; INTERVIEW; MALE; MENTAL CAPACITY; MENTAL DEFICIENCY; MOLECULAR GENETICS; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; RATING SCALE; SEIZURE;

ADULT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MALE; MASS SCREENING; MENTAL RETARDATION; NERVE TISSUE PROTEINS; POINT MUTATION; QUESTIONNAIRES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS;

EID: 12744260103     PISSN: 0196206X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004703-200412000-00002     Document Type: Article

References (54)

1. Hagerman RJ, Hagerman PJ, eds. Fragile X Syndrome: Diagnosis, Treatment and Research, 3rd ed. Baltimore: Johns Hopkins University Press; 2002:3-109.
2. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. Prevalence of carriers of permutation-size alleles of the FMRI gene- and implications for the population genetics of fragile X syndrome. Am J Hum Genet. 1995;57:1006-1018.
3. Dombrowski C, Levesque ML, Morel ML, et al. Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet. 2002;11:371-378.
4. Riddle JE, Cheema A, Sobesky WE, et al. Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard. 1998; 102:590-601.
5. Brown WT, Jenkins EC, Friedman E, et al. Autism is associated with the fragile-X syndrome. J Autism Dev Disord. 1982;12:303-308.
6. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord. 2003;33: 365-382.
7. Blomquist HK, Bohman M, Edvinsson SO, et al. Frequency of the fragile X syndrome in infantile Autism. A Swedish multicenter study. Clin Genet. 1985;27:113-117.
8. Fisch GS, Cohen IL, Jenkins EC, et al. Screening developmentally disabled male populations for fragile X: the effect of sample size. Am J Med Genet. 1988;30:655-663.
9. Goldfine PE, McPherson PM, Heath GA, et al. Association of fragile X syndrome with Autism. Am J Psychiatry. 1985;142:108-110.
10. Li SY, Chen YC, Lai TJ, et al. Molecular and cytogenetic analyses of autism in Taiwan. Hum Genet. 1993;92:441-445.
11. Brown WT, Jenkins EC, Cohen IL, et al. Fragile X and autism: a multicenter survey. Am J Med Genet. 1986;23:341-352.
12. Hagerman RJ, Jackson AWD, Levitas A, et al. An analysis of autism in fifty males with the fragile X syndrome. Am J Med Genet. 1986; 23:359-374.
13. Reiss AL, Freund L. Behavioral phenotype of fragile X syndrome: DSM-III-R autistic behavior in male children. Am J Med Genet. 1992;43:35-46.
14. Baumgardner TL, Reiss AL, Freund LS, et al. Specification of the neurobehavioral phenotype in males with fragile X syndrome. Pediatrics. 1995;95:744-752.
15. Turk J, Graham P. Fragile X syndrome, autism, and autistic features. Autism. 1997;1:175-197.
16. Bailey DB Jr, Hatton DD, Mesibov GB, et al. Early development, temperament and functional impairment in autism and fragile X syndrome. J Autism Dev Disord. 2000;30:49-59.
17. Bailey DB Jr, Hatton DD, Skinner M, et al. Autistic behavior, FMR1 protein, and developmental trajectories in young males with fragile X syndrome. J Autism Dev Disord. 2001; 31:165-174.
18. Rogers SJ, Wehner EA, Hagerman RJ. The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J Dev Behav Pediatr. 2001;22:409-417.
19. Rogers SJ, Hepburn S, Stackhouse T, Wehner E. Imitation performance in toddlers with autism and those with other developmental disorders. J Child Psychol Psychiatry. 2003;44:763-781.
20. Lord C, Rutter M, DiLavore P, et al. Autism Diagnostic Observation Schedule-WPS Edition. Los Angeles: Western Psychological Services; 1999.
21. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24:659-685.
22. Sobesky WE, Pennington BF, Porter D, et al. Emotional and neurocognitive deficits in fragile X. Am J Med Genet. 1994;51: 378-385.
23. Sobesky WE. The treatment of emotional and behavioral problems. In: Hagerman RJ, Cronister A, eds. Fragile X Syndrome: Diagnosis, Treatment, and Research. 2nd ed. Baltimore: Johns Hopkins University Press; 1996:332-348.
24. Franke P, Leboyer M, Gansicke M, et al. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res. 1998;80:113-127.
25. Johnston C, Eliez S, Dyer-Friedman J, et al. Neurobehavioral phenotype in carriers of the fragile X premutation. Am J Med Genet. 2001;103:314-319.
26. Loesch DZ, Hay DA, Mulley J. Transmitting males and carrier females in fragile X-revisited. Am J Med Genet. 1994;51:392-399.
27. Hagerman RJ, Staley LW, O'Connor R, et al. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics. 1996;97:122-126.
28. Tassone F, Hagerman RJ, Taylor AK, et al. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet. 2000;91:144-152.
29. Tassone F, Hagerman RJ, Taylor AK, et al. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in fragile X syndrome. Am J Hum Genet. 2000;66:6-15.
30. Aziz M, Stathopulu E, Callias M, et al. Clinical features of boys with fragile X premutations and intermediate alleles. Am J Med Genet. 2003;121B:119-127.
31. Jacquemont S, Hagerman RJ, Leehey M, et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003;72:869-878.
32. Jacquemont S, Hagerman R, Leehey M, et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA. 2004;291:460-469.
33. Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001;57:127-130.
34. Tassone F, Hagerman RJ, Loesch DZ, et al. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet. 2000;94: 232-236.
35. Filipek PA, Accardo PJ. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord. 1999;29:439-484.
36. Schopler E, Reichler RJ, Renner BR. Childhood Autism Rating Scale (CARS). 1993.
37. Rutter M, Bailey A, Lord C. Social Communication Questionnaire (SCQ). Los Angeles: Western Psychological Services; 2003.
38. Kaufman AS, Kaufman NL. Kaufman Assessment Battery for Children (K-ABC). Circle Pines, MN: American Guidance Service; 1983.
39. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI). San Antonio, TX: The Psychological Corporation; 1999.
40. Wechsler D. Wechsler Preschool and Primary Scales of Intelligence-3rd Edition. San Antonio, TX The Psychological Corporation; 2002.
41. Roid GH, Miller LJ. Leiter International Performance Scale-Revised. Wood Dale, IL: Stoelting Co.; 1997.
42. Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behavior Scales Survey Form Manual. Circle Pines, MN: American Guidance Service; 1984.
43. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC: American Psychiatric Association; 1994.
44. WHO. International Statistical Classification of diseases and Related Health Problems (ICD-10). Geneva: WHO; 1989, revision 1992.
45. Taylor AK, Safanda JF, Fall MZ, et al. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA. 1994;271:507-514.
46. Willemsen R, Mohkamsing S, de Vries B, et al. Rapid antibody test for fragile X syndrome. Lancet. 1995;345:1147-1148.
47. Willemsen R, Smits A, Mohkamsing S, et al. Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Hum Genet. 1997;99:308-311.
48. Hagerman PJ, Hagerman RJ. The fragile-X premutation: a maturing perspective. Am J Hum Genet. 2004;74:805-816.
49. Kenneson A, Zhang F, Hagedorn CH, et al. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet. 2001;10:1449-1454.
50. Tassone F, Hagerman RJ, Chamberlain WD, et al. Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet. 2000;97:195-203.
51. Primerano B, Tassone F, Hagerman RJ, et al. Reduced FMR1 mRNA translation efficiency in Fragile X patients with premutations. RNA 2002;8:1482-1488.
52. Tassone F, Hagerman RJ, Iklé DN, et al. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet. 1999;84:250-261.
53. Hansen R, Hagerman R. Contributions of pediatrics. In: Ozonoff S, Rogers SJ, Hendren RL, eds. Autism Spectrum Disorders: A Research Review for Practitioners. Washington, DC: American Psychiatric Publishing Inc.; 2003.
54. Farzin F, Perry H, Hessl D, et al. Phenotype of the fragile X premutation in childhood: a preliminary study. Presented at the American Society of Human Genetics Annual Meeting, October 26-29, 2004; Toronto, Canada.